Cargando...
Reversal Agents: What We Have and What We Can Expect
Clinical trials in patients with atrial fibrillation have demonstrated that non-vitamin K antagonist oral anticoagulants [novel oral anticoagulants (NOACs)] are markedly safer than warfarin with respect to serious bleeding—especially intracranial hemorrhage, the most feared and devastating complicat...
Gardado en:
| Publicado en: | J Innov Card Rhythm Manag |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MediaSphere Medical
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7252789/ https://ncbi.nlm.nih.gov/pubmed/32477806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.19102/icrm.2018.090403 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|